Former AXA Framlington Biotechnology fund manager Andy Smith has joined biopharma specialist Mann Bioinvest to launch an income-focused fund in the coming weeks.
The Magna BioPharma Income fund, slated to launch around the end of Q1 2013, will be managed by Smith, with key decisions overseen by an investment committee. Boutique equity house Charlemagne Capital...
Four potential outcomes
Industry members abseil down Broadgate Tower
Changes made on 14 September
Hired as portfolio manager in global equity income team
'Three cycles are colliding'